Loading...
The survival of patients enrolled in a global direct-to-patient cancer medicine donation program: The Glivec International Patient Assistance Program (GIPAP)
BACKGROUND: The Glivec International Patient Assistance Program (GIPAP) is a unique direct-to-patient program that provides imatinib (Glivec) at no cost to eligible patients in low- and middle-income countries (LMICs) with chronic myelogenous leukemia (CML) or gastrointestinal stromal tumor (GIST)....
Na minha lista:
| Udgivet i: | EClinicalMedicine |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7046500/ https://ncbi.nlm.nih.gov/pubmed/32140674 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eclinm.2020.100257 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|